Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics
Paras Famta, Saurabh Shah, Naitik Jain, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 166-185
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 285
In situ cellular hitchhiking of nanoparticles for drug delivery
Edidiong Udofa, Zongmin Zhao
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115143-115143
Open Access | Times Cited: 25
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 9
Albumin‐Hitchhiking Drug Delivery to Tumor‐Draining Lymph Nodes Precisely Boosts Tumor‐Specific Immunity through Autophagy Modulation of Immune Cells
Xuhui Wang, Dong Chen, Kexin Huang, et al.
Advanced Materials (2023) Vol. 35, Iss. 29
Closed Access | Times Cited: 17
Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia
Paras Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 94-106
Closed Access | Times Cited: 16
Manganese@Albumin Nanocomplex and Its Assembled Nanowire Activate TLR4‐Dependent Signaling Cascades of Macrophages
Shuodan Huang, Yan Gao, Huiying Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 5
Open Access | Times Cited: 15
Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
Lei‐Ming Cao, Yifu Yu, Zi‐Zhan Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
Jie Zang, Guochang Wang, Tianzhi Zhao, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 51, Iss. 3, pp. 871-882
Closed Access | Times Cited: 14
Recent progress of vaccines administration via microneedles for cancer immunotherapy
Yuanzheng Chen, Jiaojiao Zhu, Jinsong Ding, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 3, pp. 108706-108706
Closed Access | Times Cited: 12
Lymph node targeting for immunotherapy
Y Wang, Hua Wang
Immuno-Oncology Technology (2023) Vol. 20, pp. 100395-100395
Open Access | Times Cited: 12
Nano voyagers: Pioneering a new frontier in cancer treatment with nanorobots as drug transporters
Akshay Shinde, Sajja Bhanu Prasad, Dadi A. Srinivasarao, et al.
Applied Materials Today (2024) Vol. 38, pp. 102162-102162
Closed Access | Times Cited: 4
Half‐life extension of single‐domain antibody–drug conjugates by albumin binding moiety enhances antitumor efficacy
Quanxiao Li, Yu Kong, Yuxuan Zhong, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 4
Exploration of Multi-layered Nanofiber Adjuvant Implants of Doxorubicin and Resveratrol to Prevent Post-Surgery Tumor Recurrence and Invasion
Paras Famta, Saurabh Shah, Anamika Sharma, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105977-105977
Closed Access | Times Cited: 4
Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation
Paras Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 2, pp. 389-406
Closed Access | Times Cited: 4
Tailoring biomaterials for vaccine delivery
Yanling Zhuo, Huanxuan Zeng, Chunyu Su, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Battle of the milky way: Lymphatic targeted drug delivery for pathogen eradication
Ali Taheri, Kristen E. Bremmell, Paul Joyce, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 507-524
Open Access | Times Cited: 10
Despicable role of epithelial–mesenchymal transition in breast cancer metastasis: Exhibiting de novo restorative regimens
Paras Famta, Saurabh Shah, Biswajit Dey, et al.
Cancer Pathogenesis and Therapy (2024) Vol. 3, Iss. 1, pp. 30-47
Open Access | Times Cited: 3
Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer
Saurabh Shah, Paras Famta, Anamika Sharma, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 3
Programable Albumin-Hitchhiking Nanobodies Enhance the Delivery of STING Agonists to Potentiate Cancer Immunotherapy
John T. Wilson, Blaise R. Kimmel, Karan Arora, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapy
Dadi A. Srinivasarao, Saurabh Shah, Paras Famta, et al.
Drug Delivery and Translational Research (2024) Vol. 15, Iss. 2, pp. 407-435
Closed Access | Times Cited: 3
Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect
Jae-Hyeon Lee, Hansol Lim, Gaeun Ma, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Simvastatin-loaded Gelatin-capped Polycaprolactone Nanoparticles for the Post-operative Management of Breast Cancer
Paras Famta, Saurabh Shah, Dadi A. Srinivasarao, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106163-106163
Closed Access | Times Cited: 2
Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy
Yani Xu, Lan Yang, Min Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1329-1344
Open Access | Times Cited: 7
PH‐Triggered, Lymph Node Focused Immunodrug Release by Polymeric 2‐Propionic‐3‐Methyl‐maleic Anhydrides with Cholesteryl End Groups
Alina G. Heck, Carolina Medina‐Montano, Zifu Zhong, et al.
Advanced Healthcare Materials (2024)
Open Access | Times Cited: 1
Conjugated Human Serum Albumin/Gold-Silica Nanoparticles as Multifunctional Carrier of a Chemotherapeutic Drug
Elena Morrone, Lucie Sancey, Fabien Dalonneau, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13701-13701
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top